Viewing StudyNCT00433550

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 5:21 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00433550
Status: COMPLETED
Last Update Posted: 2017-08-24
First Post: 2007-02-08
Brief Title: Irinotecan Oxaliplatin and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
Sponsor: Alliance for Clinical Trials in Oncology
Organization: Alliance for Clinical Trials in Oncology
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Small Intestine Adenocarcinoma
Recurrent Small Intestine Cancer
Keywords: